Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (12)
Cancer statistics, 1995
1995 • 1,434 citations
General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes
1984 • 652 citations
Vaccinia Virus Expression Vectors
1987 • 272 citations
Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequence
1987 • 259 citations
Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine
1992 • 212 citations
Prospectively randomized trial of adjuvant active‐specific immunotherapy for human colorectal cancer
1985 • 164 citations
Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer
1985 • 149 citations
Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate.
1992 • 89 citations
A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA)
1991 • 87 citations
Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes
1987 • 79 citations
Serological studies of mucosal disease virus in England and Wales
1978 • 72 citations
Specific active immunotherapy in patients with adenocarcinoma of the colon utilizing tumor-associated antigens (TAA). A phase I clinical trial
1985 • 39 citations